Azade Amini Kadijani1, Abolfazl Bagherifard2, Fatemeh Mohammadi3, Abolfazl Akbari4, Farshad Zandrahimi1,5, Alireza Mirzaei2. 1. Basic and Molecular Epidemiology of Gastrointestinal Disorders Research Center, Research Institute for Gastroenterology and Liver Diseases, Shahid Beheshti University of Medical Sciences, Tehran, Iran. 2. Bone and Joint Reconstruction Research Center, Shafa Orthopedic Hospital, Iran University of Medical Sciences, Tehran, Iran. 3. Emergency Medicine Management Research Center, Iran University of Medical Sciences, Tehran, Iran. 4. Colorectal Research Center, Iran University of Medical Sciences, Tehran, Iran. 5. Kerman University of Medical Sciences, Kerman, Iran.
Abstract
OBJECTIVE: The role of vitamin D in the pathogenesis of osteoarthritis (OA) is not well understood. In this study, we aimed to investigate the association of serum vitamin D with the serum cytokine profile in patients with primary knee OA. DESIGN: In a cross-sectional study, 116 patients with radiologic diagnosis of grade I to III knee OA were included. The study population included 79 (75.9%) females and 25 (24.1%) males with a mean age of 55.1 ± 9.6 years. The serum concentration of IL-6, IL-8, TNF-α, IL-4, IL-10, IL-13, and vitamin D were assessed using an enzyme-linked immunosorbent assay. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) was used for the assessment of patient's reported disability associated with knee OA. RESULTS: Serum vitamin D status was deficient, insufficient, and sufficient in 18 (15.5%), 63 (54.3%), 35 (30.2%) patients, respectively. Higher levels of serum IL-6 were observed in patients with vitamin D deficiency (P = 0.022). The mean serum vitamin D level was not associated with OA grade (P = 0.88) and WOMAC scores of the patients (P = 0.67). Serum IL-6 level was significantly associated with both OA grade and WOMAC scores of the patients (P < 0.001 and P = 0.001, respectively). The vitamin D status was not significantly associated with the serum levels of other evaluated cytokines. CONCLUSION: Vitamin D deficiency in knee OA seems to be associated with a higher release of IL-6. Therefore, vitamin D supplementation could reduce the disease burden by controlling the IL-6 release.
OBJECTIVE: The role of vitamin D in the pathogenesis of osteoarthritis (OA) is not well understood. In this study, we aimed to investigate the association of serum vitamin D with the serum cytokine profile in patients with primary knee OA. DESIGN: In a cross-sectional study, 116 patients with radiologic diagnosis of grade I to III knee OA were included. The study population included 79 (75.9%) females and 25 (24.1%) males with a mean age of 55.1 ± 9.6 years. The serum concentration of IL-6, IL-8, TNF-α, IL-4, IL-10, IL-13, and vitamin D were assessed using an enzyme-linked immunosorbent assay. The Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) was used for the assessment of patient's reported disability associated with knee OA. RESULTS: Serum vitamin D status was deficient, insufficient, and sufficient in 18 (15.5%), 63 (54.3%), 35 (30.2%) patients, respectively. Higher levels of serum IL-6 were observed in patients with vitamin D deficiency (P = 0.022). The mean serum vitamin D level was not associated with OA grade (P = 0.88) and WOMAC scores of the patients (P = 0.67). Serum IL-6 level was significantly associated with both OA grade and WOMAC scores of the patients (P < 0.001 and P = 0.001, respectively). The vitamin D status was not significantly associated with the serum levels of other evaluated cytokines. CONCLUSION: Vitamin D deficiency in knee OA seems to be associated with a higher release of IL-6. Therefore, vitamin D supplementation could reduce the disease burden by controlling the IL-6 release.
Entities:
Keywords:
IL-6; cytokine; osteoarthritis; vitamin D
Authors: Tyler Barker; Victoria E Rogers; Mark Levy; Jenna Templeton; Howard Goldfine; Erik D Schneider; Brian M Dixon; Vanessa T Henriksen; Lindell K Weaver Journal: Cytokine Date: 2014-10-30 Impact factor: 3.861
Authors: S Muraki; E Dennison; K Jameson; B J Boucher; T Akune; N Yoshimura; A Judge; N K Arden; K Javaid; C Cooper Journal: Osteoarthritis Cartilage Date: 2011-08-16 Impact factor: 6.576
Authors: Marta Imamura; Fernando Ezquerro; Fábio Marcon Alfieri; Lucy Vilas Boas; Tania Regina Tozetto-Mendoza; Janini Chen; Levent Özçakar; Lars Arendt-Nielsen; Linamara Rizzo Battistella Journal: Int J Inflam Date: 2015-03-02
Authors: N K Arden; S Cro; S Sheard; C J Doré; A Bara; S A Tebbs; D J Hunter; S James; C Cooper; T W O'Neill; A Macgregor; F Birrell; R Keen Journal: Osteoarthritis Cartilage Date: 2016-06-02 Impact factor: 6.576
Authors: Dorottya Kardos; Bence Marschall; Melinda Simon; István Hornyák; Adél Hinsenkamp; Olga Kuten; Zsuzsanna Gyevnár; Gábor Erdélyi; Tamás Bárdos; Tamás Mirkó Paukovits; Krisztián Magos; György Béres; Kálmán Szenthe; Ferenc Bánáti; Susan Szathmary; Stefan Nehrer; Zsombor Lacza Journal: Cells Date: 2019-08-03 Impact factor: 6.600
Authors: James Bernard Walsh; Daniel M McCartney; Éamon Laird; Kevin McCarroll; Declan G Byrne; Martin Healy; Paula M O'Shea; Rose Anne Kenny; John L Faul Journal: Front Pharmacol Date: 2022-03-04 Impact factor: 5.810